SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-03-001502
Filing Date
2003-04-30
Accepted
2003-04-30 10:57:27
Documents
2
Period of Report
2003-04-30
Items
Item 7: Financial statements and exhibits
Item 9: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 AVANT IMMUNOTHERAPEUTICS, INC. 8-K a4386494.txt 8-K 3196
3 AVANT IMMUNOTHERAPEUTICS EXHIBIT 99.1 a4386494_ex991.txt EX-99 14028
  Complete submission text file 0001157523-03-001502.txt   19057
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 03671180
SIC: 2835 In Vitro & In Vivo Diagnostic Substances